OmniAb signs global collaboration and license deal with Eli Lilly
OmniAb (OABI) announces a global collaboration and license agreement for an ion channel program with Eli Lilly & Company.
Story updates
10:04:26 AM UTC
SquawkNews
OABI OmniAb gets upfront payment plus up to $370M in R&D and commercial milestones — Tiered royalties on global sales included
10:12:19 AM UTC
SquawkNews
OABI - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.